Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging: Complete Statistical AnalysisIndependent statistical analysis of Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04698564).
- Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site: Complete Statistical AnalysisIndependent statistical analysis of Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- V-DIFFERENCEIndependent statistical analysis of Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia: primary endpoint…
- V-EXTRA-CVDIndependent statistical analysis of A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: Complete Statistical AnalysisIndependent statistical analysis of VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01158157).
- VAC 2006-19Independent statistical analysis of A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds: primary endpoint results, effect estimate with…
- VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: Complete Statistical AnalysisIndependent statistical analysis of VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2): Complete Statistical AnalysisIndependent statistical analysis of Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01119703).
- Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00070070).
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds: Complete Statistical AnalysisIndependent statistical analysis of Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02803164).
- VAD00001Independent statistical analysis of Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval,…
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03189446).
- Vaginal Cuff Dehiscence and Thermal Injury During TLH: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Dehiscence and Thermal Injury During TLH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080546).
- Vaginal Preparation Prior to Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Preparation Prior to Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03412734).
- Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01962558).
- Vagus Nerve Stimulation and Stress Reduction Training for Migraine: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation and Stress Reduction Training for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03592329).
- VAL201-001Independent statistical analysis of Dose Finding Safety Study of VAL201 in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02280317).
- Valacyclovir in Neonatal Herpes Simplex Virus Disease: Complete Statistical AnalysisIndependent statistical analysis of Valacyclovir in Neonatal Herpes Simplex Virus Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04448392).
- Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss: Complete Statistical AnalysisIndependent statistical analysis of Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VALIANTIndependent statistical analysis of Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Validation of RPVi as a Parameter to Predict Fluid Responsiveness: Complete Statistical AnalysisIndependent statistical analysis of Validation of RPVi as a Parameter to Predict Fluid Responsiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03706430).
- Validation of Sleep Apnea Screening Device: Complete Statistical AnalysisIndependent statistical analysis of Validation of Sleep Apnea Screening Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02814227).
- Validation of TearLab Osmometer – Human Factor Usability Report: Complete Statistical AnalysisIndependent statistical analysis of Validation of TearLab Osmometer - Human Factor Usability Report: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00731484).
- Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057: Complete Statistical AnalysisIndependent statistical analysis of Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Validation Study of Physical Measurement of Tophi: Complete Statistical AnalysisIndependent statistical analysis of Validation Study of Physical Measurement of Tophi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00175006).
- VALOR-HCVIndependent statistical analysis of Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy – Single Arm, Multicenter, and Open-label Study: Complete Statistical AnalysisIndependent statistical analysis of Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study: primary endpoint results, effect estimate with…
- Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma: Complete Statistical AnalysisIndependent statistical analysis of Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.: Complete Statistical AnalysisIndependent statistical analysis of VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.: primary endpoint results, effect…
- Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01682837).
- Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks: Complete Statistical AnalysisIndependent statistical analysis of Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Value of Technology to Transfer Discharge Information: Complete Statistical AnalysisIndependent statistical analysis of Value of Technology to Transfer Discharge Information: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00101868).
- VANCOIndependent statistical analysis of Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO): primary endpoint results, effect estimate with…
- Vanguard TKA With KneeAlign 2 and Without KneeAlign 2: Complete Statistical AnalysisIndependent statistical analysis of Vanguard TKA With KneeAlign 2 and Without KneeAlign 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02695329).
- VANISHIndependent statistical analysis of VANISH for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04236804).
- VANISH-2Independent statistical analysis of Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…